Organon (OGN) Cash from Financing Activities (2020 - 2026)

Organon (OGN) has reported Cash from Financing Activities for 7 consecutive years, with -$38.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 49.33% year-over-year to -$38.0 million; the TTM figure through Mar 2026 stood at -$524.0 million (down 42.01% YoY), while the FY2025 annual figure was -$561.0 million, down 52.45% from the prior year.
• Cash from Financing Activities came in at -$38.0 million for Q1 2026 at Organon, up from -$187.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was -$38.0 million in Q1 2026, with the low at -$326.0 million in Q1 2023.
• Average Cash from Financing Activities over 5 years is -$115.8 million, with a median of -$82.0 million recorded in 2022.
• The largest YoY upside for Cash from Financing Activities was 91.85% in 2022 against a maximum downside of 327.78% in 2022.
• Year by year, Cash from Financing Activities stood at -$82.0 million in 2022, then climbed by 6.1% to -$77.0 million in 2023, then dropped by 6.49% to -$82.0 million in 2024, then plunged by 128.05% to -$187.0 million in 2025, then surged by 79.68% to -$38.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$38.0 million, -$187.0 million, and -$76.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.